Adar Poonawalla.

Photo: The Indian Express

Serum Institute To Invest Rs 2,400 Crore, Generate 6,500 Jobs In UK

Vaccine maker the Serum Institute of India will be investing Rs 2,400 crore in Britain to support clinical trials, research and development along with vaccine manufacturing. The deal is a part of the India-UK enhanced trade partnership, which altogether involves an investment of Rs 10,000 crore. According to sources, SII's investment aims to create 6,500 new jobs and intends to generate new business worth over $1 billion in the UK.

Tue, 04 May 2021 - 01:50 PM / by Harsh Vardhan

Tags: India, UK, trade, SII, Investment

Courtesy: The Times of India

Adar Poonawalla

Photo: Times UK

Adar Poonawalla Says Vaccine Shortage To Continue For Few Months

Serum Institute of India CEO Adar Poonawalla has stated that the vaccine shortage is likely to continue for the next few months. Currently, the company is producing 60-70 million doses of Covishield a month but eyeing to ramp up the capacity to 100 million doses per month by July. He stated that the production capacity was not upped earlier as authorities did not expect the second COVID-19 wave. 

Mon, 03 May 2021 - 03:00 PM / by Neha Sanjeev

Tags: Adar Poonawalla, SII, COVID-19 VACCINE HOARD, Vaccine Shortage

Courtesy: Times now news

Adar Poonawalla.

Photo: The Indian Express

Vaccine Maker SII's CEO Adar Poonawalla Given Y-Security Amid Threats

Vaccine-maker Serum Institute of India (SII)'s CEO Adar Poonawalla has been granted Y-category security by the Home Ministry. Based on the threat perception report and to be handled by the CRPF, the security cover will include 11 personnel comprising CRPF commandos and policemen. SII is responsible for manufacturing 'Covishield' vaccine, whose rate was recently cut for states, from Rs 400 to Rs 300, after Poonawalla announced it on April 28… read-more

Thu, 29 Apr 2021 - 09:30 AM / by Harsh Vardhan

Tags: SII, Adar Poonawalla, Covishield vaccine, Y-Category security

Courtesy: The Times of India

Covaxin

Photo: News 18

Bharat Biotech To Sell Covaxin At Rs 600 For States, Rs 1,200 For Pvt Hospitals

Bharat Biotech on April 24 announced to sell its COVID-19 vaccine Covaxin at Rs 1,200 for private hospitals and Rs 600 for state governments. The firm said that Covaxin is a "highly purified vaccine" and is expensive to manufacture. Meanwhile, the other vaccine maker, Serum Institute of India, would be selling its vaccine 'Covishield' at a price of Rs 400 for states and at Rs 600 for private hospitals.… read-more

Sun, 25 Apr 2021 - 10:38 AM / by Nikita Thakur

Tags: Bharat biotech, Covaxin, Covid Vaccine, SII

Courtesy: NDTV

Covishield vaccine

Photo: The Economic Times

SII To Sell Covishield At Rs 600 To Pvt Hospitals, Rs 400 To States

The Serum Institute of India on April 21 announced to sell its Covishield vaccine to state governments at Rs 400 and to the private hospitals at Rs 600/dose. SII said that 50% of its forthcoming vaccine production will be dedicated to Centre’s vaccination program and other 50% for states and private hospitals. Welcoming the Centre’s liberalised vaccination policy, SII assured that vaccines will be available in 4-5 months.

Wed, 21 Apr 2021 - 03:43 PM / by Harsh Vardhan

Tags: SII, COVISHIELD, Central Government, Covid-19 Vaccine, Private Hospitals

Courtesy: Live Mint

Adar Poonawalla

Photo: Business Standard

AstraZeneca Sends Legal Notice To SII Over Delays In Vaccine Supply

British-Swedish pharmaceutical company AstraZeneca has served a legal notice to the Serum Institute of India over delays in the supply of COVID-19 vaccine Covishield. SII CEO Adar Poonawalla said, “Serum Institute is not able to fulfil (contractual obligations) due to its prioritisation of Indian supplies." Moreover, denying to comment on the notice and terming it "confidential", Poonawalla said the company is trying to resolve and manage the… read-more

Thu, 08 Apr 2021 - 12:08 PM / by Nikita Thakur

Tags: COVISHIELD, Adar Poonawalla, SII, AstraZeneca

Courtesy: NDTV

Adar Poonawalla

Photo: The Economic Times

Serum Institue Plans To Launch Covovax By August: Adar Poonawalla 

The Serum Institute of India is planning to launch another COVID-19 vaccine 'Covovax' by August 2021. Developed by Novavax, an American vaccine maker, the Covovax will be stockpiled by the SII, for its testing on the Indian population, starting from April. Speaking at the Bloomberg Equity Index, SII CEO Adar Poonawalla said Covovax distribution will start after receiving the government’s nod. Poonawalla added that the global COVAX facility is… read-more

Thu, 18 Mar 2021 - 03:00 PM / by Nikita Thakur

Tags: Novavax, Adar Poonawalla, SII, Covid-19 Vaccine, COVAX, WHO

Novavax

Photo: Quartz

SII Awaits Govt Approval To Conduct Trials Of Novavax COVID Vaccine

The Serum Institute of India has applied to the Drugs Controller General of India seeking permission to conduct domestic trials of ‘Novavax’ coronavirus vaccine. Reportedly, the US-based company claimed that Novavax showed 89.3% and 60% effectiveness during the trials in the UK and Africa respectively. Earlier, Novavax and SII collaborated to produce 2 billion vaccine doses. Besides, Novavax has received around $388 million from the Coalition… read-more

Fri, 29 Jan 2021 - 01:19 PM / by Nikita Thakur

Tags: Novavax, SII, Serum Institute of India, DCGI

Courtesy: Live Mint

Serum Institute of India Pune

Photo: The Indian Express

Pune SII Fire: CEO Adar Poonawalla Estimates Rs 1,000 Cr Loss

A day after the fire outbreak at its Pune-based plant, the Serum Institute of India CEO Adar Poonawalla has admitted a financial loss of Rs 1,000 crore. Adar said, "The fire has damaged machinery installed for rotavirus and BCG vaccine production." However, has assured that the production facility of COVID-19 vaccine - Covishield - has not been affected. Moreover, three to four floors of the SII facility were damaged.

Fri, 22 Jan 2021 - 07:24 PM / by Nikita Thakur

Tags: Fire at SII, SII, Adar Poonawalla, Covishield vaccine

Courtesy: Deccan Herald

Fire At SII

Photo: DNA India

SII Announces Compensation Of Rs 25 Lakh To Families Of Deceased

Pune-based the Serum Institute of India has announced a Rs 25-lakh compensation to the families of five deceased who lost their lives in the fire outbreak on January 21. Expressing his grief, SII CEO Adar Poonawalla said, "Extremely sorrowful day for all of us". Reportedly, four other people were evacuated from the SII's Manjari premises . Meanwhile, the SII and Maharashtra CM Uddav Thackary have assured that the accident will not affect… read-more

Fri, 22 Jan 2021 - 06:50 AM / by Nikita Thakur

Tags: Serum Institute of India, SII, Fire at SII, Fire Outbreak, Pune

Courtesy: Times Now